HASHEM EL-SERAG to Stomach Neoplasms
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Stomach Neoplasms.
Connection Strength
5.557
-
Evolving Concepts in Helicobacter pylori Management. Gastroenterology. 2024 02; 166(2):267-283.
Score: 0.563
-
Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies. Dig Dis Sci. 2023 09; 68(9):3732-3744.
Score: 0.554
-
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023 05; 20(5):338-349.
Score: 0.542
-
Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol. 2022 01 01; 56(1):e71-e76.
Score: 0.498
-
Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol. 2021 02; 19(2):269-276.e3.
Score: 0.440
-
Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 03; 18(3):534-542.
Score: 0.421
-
Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007 Sep; 14(9):2519-27.
Score: 0.182
-
Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006 Nov; 101(11):2485-92.
Score: 0.173
-
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut. 2024 Sep 09; 73(10):1607-1617.
Score: 0.150
-
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024 02 23; 73(3):407-441.
Score: 0.145
-
Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45.
Score: 0.143
-
Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):432-439.
Score: 0.138
-
Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma. Dig Dis Sci. 2023 03; 68(3):761-769.
Score: 0.128
-
Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia. Clin Gastroenterol Hepatol. 2023 01; 21(1):64-71.
Score: 0.128
-
Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002 Mar; 50(3):368-72.
Score: 0.126
-
Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol. 2022 02 01; 117(2):280-287.
Score: 0.125
-
Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Dig Dis Sci. 2022 09; 67(9):4500-4508.
Score: 0.124
-
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. Dig Liver Dis. 2021 01; 53(1):61-65.
Score: 0.114
-
Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci. 2021 05; 66(5):1669-1672.
Score: 0.112
-
Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
Score: 0.112
-
Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply. Aliment Pharmacol Ther. 2020 06; 51(12):1447-1449.
Score: 0.112
-
Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699.
Score: 0.108
-
Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci. 2020 08; 65(8):2403-2411.
Score: 0.107
-
Ethnic variations in the occurrence of gastroesophageal cancers. J Clin Gastroenterol. 1999 Mar; 28(2):135-9.
Score: 0.102
-
Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017 Dec; 15(12):1833-1843.
Score: 0.090
-
Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017 04 01; 140(7):1693-1699.
Score: 0.088
-
Opposing time trends of peptic ulcer and reflux disease. Gut. 1998 Sep; 43(3):327-33.
Score: 0.025
-
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998 May; 43(5):1001-8.
Score: 0.006